cefuroxime has been researched along with Bacterial Eye Infections in 74 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intracameral injection of cefuroxime reduces the risk of postoperative infectious endophthalmitis following phacoemulsification cataract surgery." | 9.13 | [Will intracameral cefuroxime become the new standard in endophthalmitis prevention?]. ( Geldsetzer, K; Pleyer, U, 2008) |
| "Results of the landmark European Society of Cataract and Refractive Surgeons trial and additional prospective and retrospective studies support the use of intracameral cefuroxime in the prophylaxis of endophthalmitis following cataract surgery." | 8.89 | Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery. ( Keating, GM, 2013) |
| "Although topical antibiotics have been used as antimicrobial prophylaxis after ocular surgery, recent studies have determined that intracameral cefuroxime at the end of surgery significantly reduce the risk to suffer an infection and suggest that the use of topical antibiotics in the prophylaxis of infectious postoperative endophthalmitis (IPOE) is controversial." | 7.88 | Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops. ( Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J, 2018) |
| "To compare the efficacy of intracameral vancomycin, cefuroxime, and moxifloxacin on postoperative bacterial endophthalmitis rates." | 7.85 | Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin. ( Libre, PE; Mathews, S, 2017) |
| "The use of intracameral cefuroxime could significantly reduce the rate of postoperative endophthalmitis in a tertiary centre in Hong Kong." | 7.83 | Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong. ( Li, KK; Li, PS; Ng, AL; Tang, WW, 2016) |
| "Patients who had cataract surgery with licensed cefuroxime prophylaxis between March 1, 2013, and July 31, 2015, and developed endophthalmitis were included." | 7.83 | Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime. ( Beral, L; David, T; Farès, S; Hage, R; Merle, H; Mesnard, C, 2016) |
| "There is not strong evidence to support use of intracameral cefuroxime to reduce the rate of acute endophthalmitis after cataract surgery; however, the marginal benefit might justify its use." | 7.81 | Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. ( Das, S; Dhillon, V; Rath, S; Sahu, SK; Sharma, S, 2015) |
| "Intracameral cefuroxime is recommended as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery." | 7.81 | Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis. ( Davey, K; Johnson, M; Pietri, G; Purslow, C; Suri, G, 2015) |
| "Intracameral cefuroxime reduced the incidence of endophthalmitis in cataract surgery and had a high clinical and economic impact on its prevention." | 7.79 | Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery. ( Andrés-Alba, Y; Arias-Puente, A; García-Sáenz, MC; Rodríguez-Caravaca, G; Villar-Del-Campo, MC, 2013) |
| "Intracameral cefuroxime injection at the end of cataract surgery was safe and significantly decreased the incidence of endophthalmitis." | 7.78 | Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. ( Adenis, JP; Barreau, G; Marin, B; Mounier, M; Robert, PY, 2012) |
| "To determine the differences in the endophthalmitis rates in cataract surgery before and after prophylactic use of intracameral cefuroxime." | 7.76 | Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study. ( Arias-Puente, A; Bañuelos, JB; García-Sáenz, MC; Rodríguez-Caravaca, G, 2010) |
| "Intracameral cefuroxime was a safe alternative to subconjunctival cefuroxime and led to a lower rate of endophthalmitis." | 7.74 | Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. ( Allen, D; Hildreth, AJ; Morgan, SJ; Steel, DH; Yu-Wai-Man, P, 2008) |
| "Intracameral cefuroxime 1 mg appeared to effectively inhibit sensitive bacterial strains and was associated with a low frequency of postoperative endophthalmitis." | 7.71 | Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. ( Koranyi, G; Montan, PG; Rylander, M; Wejde, G, 2002) |
| "Intracameral injection of cefuroxime reduces the risk of postoperative infectious endophthalmitis following phacoemulsification cataract surgery." | 5.13 | [Will intracameral cefuroxime become the new standard in endophthalmitis prevention?]. ( Geldsetzer, K; Pleyer, U, 2008) |
| "Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis." | 5.12 | Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. ( , 2007) |
| "Intracameral cefuroxime administered at the time of surgery significantly reduced the risk for developing endophthalmitis after cataract surgery." | 5.12 | ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. ( Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV, 2006) |
| "This partially masked randomized placebo-controlled multinational clinical study was designed to evaluate prospectively the prophylactic effect of intracameral cefuroxime and/or perioperative topical levofloxacin on postoperative endophthalmitis after cataract surgery." | 5.12 | ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study. ( Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV; Wilhelmus, KR, 2006) |
| "Intracameral cefuroxime and moxifloxacin reduced endophthalmitis rates compared with controls with minimal or no toxicity events at standard doses." | 4.98 | Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. ( Ambati, BK; Bardsley, T; Bondalapati, S; Bowen, RC; Evans, PR; Greene, T; Kliethermes, M; Lawyer, TW; Mamalis, CA; McFarland, M; Rudnisky, CJ; Shi, D; Snow, KB; Zhou, AX, 2018) |
| "Results of the landmark European Society of Cataract and Refractive Surgeons trial and additional prospective and retrospective studies support the use of intracameral cefuroxime in the prophylaxis of endophthalmitis following cataract surgery." | 4.89 | Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery. ( Keating, GM, 2013) |
| "The primary aim of this three centre non-randomised retrospective database cohort study of 7,532 PPV procedures was to identify the rate of endophthalmitis in cohorts of patients treated with intracameral or subconjunctival cefuroxime." | 4.02 | Safety of intracameral cefuroxime in pars plana vitrectomy. ( Kumaran, N; Laidlaw, DAH; Neffendorf, JE; Sandinha, T; Williamson, TH; Wong, RS, 2021) |
| "Endophthalmitis cases with positive cultures were generally related to organism resistance in cefuroxime eyes but to sensitive organisms in moxifloxacin eyes." | 4.02 | Endophthalmitis Prophylaxis Failures in Patients Injected With Intracameral Antibiotic During Cataract Surgery. ( Carolan, JA; Herrinton, L; Liu, L; Shorstein, NH, 2021) |
| "To create a model of the abatement profiles of the three most commonly employed endophthalmitis prophylaxis intracameral (IC) antibiotics-cefuroxime, vancomycin, and moxifloxacin-to enable comparison of their durations of efficacy against common endophthalmitis pathogens." | 3.91 | Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies. ( Arshinoff, SA; Felfeli, T; Modabber, M, 2019) |
| "Although topical antibiotics have been used as antimicrobial prophylaxis after ocular surgery, recent studies have determined that intracameral cefuroxime at the end of surgery significantly reduce the risk to suffer an infection and suggest that the use of topical antibiotics in the prophylaxis of infectious postoperative endophthalmitis (IPOE) is controversial." | 3.88 | Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops. ( Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J, 2018) |
| "To compare the efficacy of intracameral vancomycin, cefuroxime, and moxifloxacin on postoperative bacterial endophthalmitis rates." | 3.85 | Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin. ( Libre, PE; Mathews, S, 2017) |
| "The use of intracameral cefuroxime could significantly reduce the rate of postoperative endophthalmitis in a tertiary centre in Hong Kong." | 3.83 | Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong. ( Li, KK; Li, PS; Ng, AL; Tang, WW, 2016) |
| "Patients who had cataract surgery with licensed cefuroxime prophylaxis between March 1, 2013, and July 31, 2015, and developed endophthalmitis were included." | 3.83 | Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime. ( Beral, L; David, T; Farès, S; Hage, R; Merle, H; Mesnard, C, 2016) |
| "Intracameral cefuroxime is recommended as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery." | 3.81 | Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis. ( Davey, K; Johnson, M; Pietri, G; Purslow, C; Suri, G, 2015) |
| "There is not strong evidence to support use of intracameral cefuroxime to reduce the rate of acute endophthalmitis after cataract surgery; however, the marginal benefit might justify its use." | 3.81 | Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. ( Das, S; Dhillon, V; Rath, S; Sahu, SK; Sharma, S, 2015) |
| "Intracameral cefuroxime reduced the incidence of endophthalmitis in cataract surgery and had a high clinical and economic impact on its prevention." | 3.79 | Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery. ( Andrés-Alba, Y; Arias-Puente, A; García-Sáenz, MC; Rodríguez-Caravaca, G; Villar-Del-Campo, MC, 2013) |
| "Intracameral cefuroxime injection at the end of cataract surgery was safe and significantly decreased the incidence of endophthalmitis." | 3.78 | Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. ( Adenis, JP; Barreau, G; Marin, B; Mounier, M; Robert, PY, 2012) |
| "To analyse the spectrum of bacterial keratitis isolates and their in vitro antibiotic susceptibilities over a 10-year period in Oxford, UK; and to compare the in vitro efficacy of ciprofloxacin with that of the combination of gentamicin and cefuroxime over the same period." | 3.77 | In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. ( Bowler, IC; Hornby, SJ; Orlans, HO, 2011) |
| "To determine the differences in the endophthalmitis rates in cataract surgery before and after prophylactic use of intracameral cefuroxime." | 3.76 | Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study. ( Arias-Puente, A; Bañuelos, JB; García-Sáenz, MC; Rodríguez-Caravaca, G, 2010) |
| "Intracameral cefuroxime was a safe alternative to subconjunctival cefuroxime and led to a lower rate of endophthalmitis." | 3.74 | Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. ( Allen, D; Hildreth, AJ; Morgan, SJ; Steel, DH; Yu-Wai-Man, P, 2008) |
| "Intracameral cefuroxime 1 mg appeared to effectively inhibit sensitive bacterial strains and was associated with a low frequency of postoperative endophthalmitis." | 3.71 | Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. ( Koranyi, G; Montan, PG; Rylander, M; Wejde, G, 2002) |
| "Intracameral cefuroxime 1 mg appears safe in terms of local toxicity." | 2.70 | Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. ( Montan, PG; Rylander, M; Setterquist, H; Wejde, G; Zetterström, C, 2002) |
| "Ofloxacin is a potent broad-spectrum fluoroquinolone antibiotic commercially available as a topical ophthalmic preparation." | 2.68 | Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. ( , 1997) |
| "Cefuroxime was the intracameral antibiotic used in 99% of treated cases." | 1.42 | Risk factors for endophthalmitis after cataract surgery: Predictors for causative organisms and visual outcomes. ( Friling, E; Lundström, M; Montan, P, 2015) |
| "Post-LASIK keratitis is usually due to gram-positive bacteria or opportunistic/atypical microorganisms located beneath the corneal flap." | 1.40 | [Keratitis after laser in situ keratomileusis (LASIK). A different entity and treatment management]. ( Ahmed, HJ; Ahmed, S; Holm, LM, 2014) |
| "Tobramycin was more potent (P = 0." | 1.39 | In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection. ( Karenchak, LM; Kowalski, RP; Kowalski, TA; Mah, FS; Romanowski, EG; Shanks, RM, 2013) |
| "Ciprofloxacin resistance was found in 8 (17." | 1.37 | Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom. ( Baker, M; Gurbaxani, A; Nash, J; Shalchi, Z, 2011) |
| "A 12-year-old boy with two weeks of relapsing fevers 10 days after camping in remote eastern Oregon was examined." | 1.33 | Borrelia hermsii causing relapsing Fever and uveitis. ( Lim, LL; Rosenbaum, JT, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (6.76) | 18.2507 |
| 2000's | 18 (24.32) | 29.6817 |
| 2010's | 41 (55.41) | 24.3611 |
| 2020's | 10 (13.51) | 2.80 |
| Authors | Studies |
|---|---|
| Melega, MV | 1 |
| Alves, M | 1 |
| Lira, RPC | 1 |
| Agarwal, A | 1 |
| Arshinoff, SA | 1 |
| Felfeli, T | 1 |
| Modabber, M | 1 |
| Rathi, VM | 1 |
| Sharma, S | 2 |
| Das, T | 1 |
| Khanna, RC | 1 |
| Agarwal, M | 1 |
| Patnaik, G | 1 |
| Sanghvi, K | 1 |
| Anand, AR | 1 |
| Janani, MK | 1 |
| Biswas, J | 1 |
| Neffendorf, JE | 1 |
| Kumaran, N | 1 |
| Sandinha, T | 1 |
| Wong, RS | 1 |
| Laidlaw, DAH | 1 |
| Williamson, TH | 1 |
| Shorstein, NH | 2 |
| Liu, L | 1 |
| Carolan, JA | 1 |
| Herrinton, L | 1 |
| Yang, Y | 1 |
| Sui, W | 1 |
| Duan, F | 1 |
| Li, Y | 1 |
| Zeng, J | 1 |
| Jiang, Z | 1 |
| Liu, M | 1 |
| Yuan, Z | 1 |
| Lin, X | 1 |
| Chang, DF | 1 |
| Porwal, AC | 1 |
| Patel, A | 1 |
| Mathew, BC | 1 |
| Jethani, JN | 1 |
| Olson, RJ | 1 |
| Ng, AL | 2 |
| Li, PS | 2 |
| Li, KK | 2 |
| Lim, LW | 3 |
| Tan, CS | 3 |
| Libre, PE | 1 |
| Mathews, S | 1 |
| Bowen, RC | 1 |
| Zhou, AX | 1 |
| Bondalapati, S | 1 |
| Lawyer, TW | 1 |
| Snow, KB | 1 |
| Evans, PR | 1 |
| Bardsley, T | 1 |
| McFarland, M | 1 |
| Kliethermes, M | 1 |
| Shi, D | 1 |
| Mamalis, CA | 1 |
| Greene, T | 1 |
| Rudnisky, CJ | 1 |
| Ambati, BK | 1 |
| Chatterjee, S | 1 |
| Agrawal, D | 1 |
| Tuñí-Picado, J | 1 |
| Martínez-Palmer, A | 1 |
| Fernández-Sala, X | 1 |
| Barceló-Vidal, J | 1 |
| Castilla-Martí, M | 1 |
| Cartagena-Guardado, Y | 1 |
| Grau, S | 1 |
| Sül, S | 1 |
| Karalezli, A | 1 |
| Tavassoli, S | 1 |
| Nayar, G | 1 |
| Darcy, K | 1 |
| Grzeda, M | 1 |
| Luck, J | 1 |
| Williams, OM | 1 |
| Tole, D | 1 |
| Rodríguez-Caravaca, G | 3 |
| García-Sáenz, MC | 3 |
| Villar-Del-Campo, MC | 1 |
| Andrés-Alba, Y | 1 |
| Arias-Puente, A | 3 |
| Zhang, MG | 1 |
| Chen, TS | 1 |
| Lau, OC | 1 |
| McPherson, ZE | 2 |
| Kam, AK | 1 |
| Ruan, C | 1 |
| Francis, KE | 1 |
| Agar, A | 2 |
| Francis, IC | 4 |
| Sim, BW | 1 |
| Williams, SC | 1 |
| Lim, CH | 1 |
| Aulia, FA | 1 |
| Yun, ST | 1 |
| Singh, R | 1 |
| Ahmed, S | 1 |
| Ahmed, HJ | 1 |
| Holm, LM | 1 |
| Sahu, SK | 1 |
| Dhillon, V | 1 |
| Das, S | 1 |
| Rath, S | 1 |
| Katz, G | 2 |
| Blum, S | 1 |
| Leeva, O | 1 |
| Axer-Siegel, R | 1 |
| Moisseiev, J | 1 |
| Tesler, G | 1 |
| Ehrlich, R | 2 |
| Cheong, KX | 1 |
| Purslow, C | 1 |
| Davey, K | 1 |
| Johnson, M | 1 |
| Pietri, G | 1 |
| Suri, G | 1 |
| Lundström, M | 2 |
| Friling, E | 1 |
| Montan, P | 2 |
| Jabbarvand, M | 1 |
| Hashemian, H | 1 |
| Khodaparast, M | 1 |
| Jouhari, M | 1 |
| Tabatabaei, A | 1 |
| Rezaei, S | 1 |
| Chow, VS | 1 |
| Creuzot-Garcher, C | 1 |
| Benzenine, E | 1 |
| Mariet, AS | 1 |
| de Lazzer, A | 1 |
| Chiquet, C | 1 |
| Bron, AM | 1 |
| Quantin, C | 1 |
| Grzybowski, A | 2 |
| Tang, WW | 1 |
| Oh, LJ | 1 |
| Nguyen, CL | 1 |
| Wang, SS | 1 |
| Mesnard, C | 1 |
| Beral, L | 1 |
| Hage, R | 1 |
| Merle, H | 1 |
| Farès, S | 1 |
| David, T | 1 |
| Barry, P | 4 |
| Konstantopoulos, A | 2 |
| Kuo, J | 1 |
| Anderson, D | 1 |
| Hossain, P | 2 |
| Pleyer, U | 1 |
| Geldsetzer, K | 1 |
| Gardner, S | 1 |
| Seal, D | 1 |
| Gettinby, G | 3 |
| Lees, F | 3 |
| Peterson, M | 3 |
| Revie, C | 1 |
| Roufas, A | 1 |
| Figueira, EC | 1 |
| Pandya, VB | 1 |
| Bhardwaj, G | 1 |
| Chui, J | 1 |
| Bañuelos, JB | 1 |
| Anijeet, D | 1 |
| Khan, IJ | 1 |
| Hamada, S | 1 |
| Rauz, S | 1 |
| Yadegarfar, G | 1 |
| Fievez, M | 1 |
| Anderson, DF | 2 |
| Andrés Alba, Y | 1 |
| Bañuelos Bañuelos, J | 1 |
| Pandita, A | 1 |
| Murphy, C | 1 |
| Orlans, HO | 1 |
| Hornby, SJ | 1 |
| Bowler, IC | 1 |
| Shalchi, Z | 1 |
| Gurbaxani, A | 1 |
| Baker, M | 1 |
| Nash, J | 1 |
| Barreau, G | 1 |
| Mounier, M | 1 |
| Marin, B | 1 |
| Adenis, JP | 1 |
| Robert, PY | 1 |
| Winthrop, KL | 1 |
| Herrinton, LJ | 1 |
| van der Merwe, J | 1 |
| Mustak, H | 1 |
| Cook, C | 1 |
| Kowalski, RP | 1 |
| Kowalski, TA | 1 |
| Shanks, RM | 1 |
| Romanowski, EG | 1 |
| Karenchak, LM | 1 |
| Mah, FS | 1 |
| Keating, GM | 1 |
| Hegde, V | 1 |
| Smith, G | 1 |
| Choi, J | 1 |
| Pagliarini, S | 1 |
| Seal, DV | 2 |
| Revie, CW | 2 |
| Wilhelmus, KR | 1 |
| Lim, LL | 1 |
| Rosenbaum, JT | 1 |
| Bohigian, GM | 1 |
| Wejde, G | 3 |
| Stenevi, U | 1 |
| Thorburn, W | 1 |
| Spokes, DM | 1 |
| Walters, G | 1 |
| Kailasanathan, A | 1 |
| Wood, M | 1 |
| Bowman, R | 1 |
| Daya, SM | 1 |
| Munir, WM | 1 |
| El Mallah, MK | 1 |
| Janda, WM | 1 |
| Tu, EY | 1 |
| Yu-Wai-Man, P | 1 |
| Morgan, SJ | 1 |
| Hildreth, AJ | 1 |
| Steel, DH | 1 |
| Allen, D | 1 |
| Steele, RJ | 1 |
| Meyer, DR | 1 |
| Patrick, CC | 1 |
| Furuta, GT | 1 |
| Edwards, M | 1 |
| Estabrook, M | 1 |
| Blake, MS | 1 |
| Baker, CJ | 1 |
| Beatty, S | 1 |
| Tyagi, A | 1 |
| Kirkby, GR | 1 |
| Morlet, N | 1 |
| Minassian, D | 1 |
| Butcher, J | 1 |
| Montan, PG | 2 |
| Koranyi, G | 1 |
| Rylander, M | 2 |
| Setterquist, H | 1 |
| Zetterström, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intraocular Concentrations Study (Aqueous Humor, Vitreous Humor) of Antibiotics After Local and/or Systemic Administration in Endophthalmitis[NCT03968341] | 5 participants (Actual) | Interventional | 2020-12-09 | Active, not recruiting | |||
| Evaluating the Efficacy, Compliance, and Patient Satisfaction of a New Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population[NCT05157113] | Phase 4 | 70 participants (Anticipated) | Interventional | 2022-05-31 | Recruiting | ||
| Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery: a Controlled and Randomized Clinical Trial[NCT02770729] | Phase 3 | 3,640 participants (Actual) | Interventional | 2017-01-31 | Terminated | ||
| The Effects on Betadine 5% Penetration When Using Lidocaine 2% Jelly Versus Topical Tetracaine 0.5% for Topical Phacoemulsification Cataract Surgery.[NCT00827073] | 40 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| Antibiotic Prophylaxis for Cataract Surgery Version 7e January 22 2003[NCT00136344] | 35,000 participants | Interventional | 2003-09-30 | Completed | |||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| Intracameral Levofloxacin (0.5%) Versus Intracameral Cefuroxime (1mg/0.1ml) Effect on Corneal Endothelial Cell Count and Morphology in Uneventful Phacoemulsification[NCT04212078] | Phase 1/Phase 2 | 138 participants (Anticipated) | Interventional | 2019-07-29 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Within 3 hours from time of culture acquisition, the samples will be vortexed for 30 seconds and 100µl aliquots will be plated onto 5% sheep blood and chocolate agar plates. These plates will be incubated with 5% carbon dioxide at 35˚ C for 72 hours. After 72 hours all plates will be read for colony count and identification of all isolates will be performed using routine microbiological methods. The natural log of bacterial bacterial colony count will be used for the outcome measure. (NCT00827073)
Timeframe: (1) Pre-antibiotics swab, and (2) Post-study medication (pre surgery)
| Intervention | Ln(bacterial colony count) (Mean) |
|---|---|
| Tetracaine 0.5% Drop | -0.14 |
| Lidocaine 2% Jelly | -0.52 |
(NCT00827073)
Timeframe: (1) Pre-antibiotics swab and (2) Post-study medication (pre surgery)
| Intervention | bacterial spceies (Mean) | |
|---|---|---|
| pre number of bacterial spices | post surgery number of bacterial speices | |
| Lidocaine 2% Jelly | 1 | 1 |
| Tetracaine 0.5% Drop | 1 | 1 |
2 reviews available for cefuroxime and Bacterial Eye Infections
| Article | Year |
|---|---|
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2018 |
Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2013 |
9 trials available for cefuroxime and Bacterial Eye Infections
| Article | Year |
|---|---|
Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prop | 2020 |
The ESCRS postoperative endophthalmitis prospective trial 15 years later.
Topics: Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; | 2021 |
[Will intracameral cefuroxime become the new standard in endophthalmitis prevention?].
Topics: Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Europe; Eye Infections, Bacterial; Female; Human | 2008 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefuroxime; Cephalosporins; Cornea; Corneal | 1997 |
Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Infective Agents; Cefuroxime; Cephalosporins; Eye Infectio | 1999 |
Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery.
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Aqueous Humor; Cefuroxime; Cell Count; Cephalospori | 2002 |
63 other studies available for cefuroxime and Bacterial Eye Infections
| Article | Year |
|---|---|
Why do scientific advances take so long to be incorporated into clinical practice? The case of intracameral injection of antibiotics to prevent acute endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; | 2022 |
Commentary: Preventing endophthalmitis after cataract surgery: An update.
Topics: Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, B | 2022 |
Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Bacteria; Cataract Extraction; Cefurox | 2019 |
Clinicopathological, Microbiological and Polymerase Chain Reaction Study in a Case of Nocardia Scleritis.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Cefuroxime; DNA, Bacterial; Drug Combi | 2021 |
Safety of intracameral cefuroxime in pars plana vitrectomy.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Cohort Studies; Endophthal | 2021 |
Endophthalmitis Prophylaxis Failures in Patients Injected With Intracameral Antibiotic During Cataract Surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Cefuroxime; Endophthalmit | 2021 |
Post-traumatic endophthalmitis caused by streptococcus species in preschool children: clinical features, antibiotic susceptibilities and outcomes.
Topics: Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Endophthalmitis; Eye Infections, Bacteri | 2022 |
The ESCRS intracameral cefuroxime study: the debate continues.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2021 |
Incidence of postoperative endophthalmitis with and without use of intracameral moxifloxacin.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infec | 2021 |
Author's reply: Re: Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2017 |
Intracameral cefuroxime in the prevention of postoperative endophthalmitis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2017 |
Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacteria | 2017 |
5% cefuroxime as an alternative to 5% cefazolin in the treatment of Gram-positive bacterial keratitis.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Dose-Response Relationship, Drug; Eye Infections, Bact | 2018 |
Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azi | 2018 |
Development of Retinal Infarct Due to Intracameral Cefuroxime Injection Following Complicated Cataract Surgery
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infec | 2018 |
An 11-year analysis of microbial keratitis in the South West of England using brain-heart infusion broth.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Brain; Cefuroxime; Corneal Ulcer; Culture Media; Engla | 2019 |
Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; | 2013 |
Endophthalmitis in Cape Town, South Africa: are the data real?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye | 2013 |
Endophthalmitis in Spain: more than meets the eye?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye | 2014 |
[Keratitis after laser in situ keratomileusis (LASIK). A different entity and treatment management].
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Eye Infections, Bacterial; Humans; Keratitis; Keratomileus | 2014 |
Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India.
Topics: Adolescent; Adult; Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidim | 2015 |
Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Bacteria; Cataract Extracti | 2015 |
Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacteria | 2015 |
Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Budgets; Cataract Extraction; Cefur | 2015 |
Risk factors for endophthalmitis after cataract surgery: Predictors for causative organisms and visual outcomes.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Gr | 2015 |
Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2016 |
Re: "Incidence of post-cataract endophthalmitis with intracameral cefuroxime" letter to the editor.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Incidence of post-cataract endophthalmitis with intracameral cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; | 2016 |
Incidence of Acute Postoperative Endophthalmitis after Cataract Surgery: A Nationwide Study in France from 2005 to 2014.
Topics: Acute Disease; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; | 2016 |
Has the Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the Time of Cataract Surgery?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; | 2016 |
Has the Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the Time of Cataract Surgery?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231).
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Endophthal | 2017 |
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231).
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Endophthal | 2017 |
Assessment of the use of anterior segment optical coherence tomography in microbial keratitis.
Topics: Adult; Aged; Anterior Eye Segment; Anti-Bacterial Agents; Cefuroxime; Contact Lenses; Corneal Ulcer; | 2008 |
Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Eye Diseases; Eye Infec | 2009 |
Endophthalmitis following cataract surgery: the sucking corneal wound.
Topics: Anti-Bacterial Agents; Cefuroxime; Cornea; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens | 2009 |
Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2010 |
Endophthalmitis after cataract surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacteria | 2010 |
Infectious crystalline keratopathy treated with intrastromal antibiotics.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Corneal Diseases; Corneal Stroma; Eye Infectio | 2010 |
In vivo quantification of bacterial keratitis with optical coherence tomography.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Cornea; Corneal Ulcer; Drug Monit | 2011 |
[Endophthalmitis after cataract surgery: epidemiology, clinical features and antibiotic prophylaxis].
Topics: Acute Disease; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophyla | 2010 |
Microbial keratitis in Waikato, New Zealand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Child; Child, Preschool; Corneal Ulcer; Eye | 2011 |
In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.
Topics: Anti-Bacterial Agents; Bacteria; Cefuroxime; Ciprofloxacin; Drug Resistance, Microbial; England; Eye | 2011 |
Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Cefurox | 2011 |
Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Ba | 2012 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Endophthalmitis prophylaxis with intracameral cefuroxime in South Africa.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2012 |
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cefuroxime; Corneal Ulcer; Drug Therapy, Combinatio | 2013 |
A case of gonococcal kerato-conjunctivitis mimicking orbital cellulitis.
Topics: Adult; Ceftriaxone; Cefuroxime; Cellulitis; Diagnosis, Differential; Drug Therapy, Combination; Eye | 2005 |
Borrelia hermsii causing relapsing Fever and uveitis.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Borrelia; Ceftriaxone; Cefuroxime; Child; Doxycycline; | 2006 |
ESCRS study of endophthalmitis prophylaxis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxim | 2007 |
Prophylaxis of postoperative endophthalmitis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2007 |
Infectious crystalline keratopathy caused by Gemella haemolysans.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Corneal Diseases; Drug Therapy, Combinat | 2007 |
Prophylactic cefuroxime and endophthalmitis in Tanzania, East Africa.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye In | 2008 |
Gemella haemolysans infectious crystalline keratopathy.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Corneal Diseases; Drug Therapy, Combinat | 2008 |
Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Conjunctiva; Endophthal | 2008 |
Nasolacrimal duct obstruction and acute dacryocystitis associated with infectious mononucleosis (Epstein-Barr virus)
Topics: Cefuroxime; Cephalosporins; Child; Dacryocystitis; Drug Therapy, Combination; Erythromycin; Eye Infe | 1993 |
Variation in phenotypic expression of the Opa outer membrane protein and lipooligosaccharide of Neisseria meningitidis serogroup C causing periorbital cellulitis and bacteremia.
Topics: Antigens, Bacterial; Bacteremia; Bacterial Outer Membrane Proteins; Cefuroxime; Cellulitis; Electrop | 1993 |
Klebsiella keratitis complicating bandage contact lens use.
Topics: Aged; Aged, 80 and over; Atropine; Bandages; Cefuroxime; Contact Lenses; Cornea; Drug Therapy, Combi | 1998 |
Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; | 2002 |